Clinical Trials Directory

Trials / Unknown

UnknownNCT03015298

Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer

Comparing the Diagnostic Role of 18F-FDG PET/MRI and of 18F-FDG PET/CT Among Patients With Gastric Cancer:A Randomized Controlled Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The results of PET/MRI and PET/CT in each recruited gastric cancer patients will be compared.

Detailed description

A prospective comparison of PET/MRI and PET/CT for gastric cancer will be performed,to evaluate the value of PET/MRI in predicting the preoperative staging and resectability of gastric cancer and investigate the role of PET/MRI in gastric cancer diagnosis.The evaluation parameters are the diagnostic accuracy of gastric cancer staging( including the overall accuracy, sensitivity, and specificity) and the receiver operating characteristic (ROC).

Conditions

Interventions

TypeNameDescription
DEVICEPET/MRIThe recruited patients will receive a PET/MRI examination to evaluation the stage and resectability of the cancer.
DEVICEPET/CTAt the next day of PET/MRI examination,A PET/CT examination will be performed.

Timeline

Start date
2017-01-01
Primary completion
2017-12-01
Completion
2018-06-01
First posted
2017-01-10
Last updated
2017-01-10

Source: ClinicalTrials.gov record NCT03015298. Inclusion in this directory is not an endorsement.